Andreas A Argyriou

Summary

Affiliation: University of Athens
Country: Greece

Publications

  1. ncbi Clinical and epidemiological features of motor neuron disease in south-western Greece
    A A Argyriou
    Department of Neurology, University Hospital of Patras, Patras, Greece
    Acta Neurol Scand 111:108-13. 2005
  2. doi Peripheral nerve damage associated with administration of taxanes in patients with cancer
    Andreas A Argyriou
    Department of Clinical Neurophysiology, National Hospital for Neurology and Neurosurgery, UCL, Institute for Neurology, Queen Square, London WC1N3BG, UK
    Crit Rev Oncol Hematol 66:218-28. 2008
  3. ncbi The impact of paclitaxel or cisplatin-based chemotherapy on sympathetic skin response: a prospective study
    A A Argyriou
    Department of Neurology, University of Patras Medical School, Rion, Greece
    Eur J Neurol 12:858-61. 2005
  4. ncbi Paclitaxel plus carboplatin-induced peripheral neuropathy. A prospective clinical and electrophysiological study in patients suffering from solid malignancies
    Andreas A Argyriou
    Dept of Neurology, Laboratory of Clinical Neurophysiology, University of Patras Medical School, P O Box 1045, Rion, Patras, Greece
    J Neurol 252:1459-64. 2005
  5. doi Religiosity and its relation to quality of life in primary caregivers of patients with multiple sclerosis: a case study in Greece
    Andreas A Argyriou
    Department of Neurology, Saint Andrew s State General Hospital of Patras, 26335, Patras, Greece
    J Neurol 258:1114-9. 2011
  6. ncbi Intracerebral haemorrhage as a rare complication of HSV-1 meningoencephalitis: case report and review of the literature
    Andreas A Argyriou
    Department of Neurology, Division of Infectious Diseases of the University Hospital of Patras, Rion Patras, Greece
    Scand J Infect Dis 38:63-6. 2006
  7. pmc Molecularly targeted therapies for dysimmune neuropathies
    Andreas A Argyriou
    Department of Neurology, Saint Andrew s State General Hospital of Patras, Greece
    Mol Med 15:283-7. 2009
  8. doi Cocaine use and abuse triggering sporadic young-onset amyotrophic lateral sclerosis
    Andreas A Argyriou
    Department of Neurology, Saint Andrew s State General Hospital of Patras, Patras, Greece
    Neurodegener Dis 8:146-8. 2011
  9. ncbi Clinical and electrophysiological features of peripheral neuropathy induced by administration of cisplatin plus paclitaxel-based chemotherapy
    A A Argyriou
    Department of Neurology Laboratory of Clinical Neurophysiology, University of Patras Medical School, Rion Patras, Greece
    Eur J Cancer Care (Engl) 16:231-7. 2007
  10. ncbi Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy
    A A Argyriou
    Neurology Department, EMG ENG Laboratory, University of Patras Medical School, 26504, Rion Patras, Greece
    Neurology 67:2253-5. 2006

Collaborators

Detail Information

Publications71

  1. ncbi Clinical and epidemiological features of motor neuron disease in south-western Greece
    A A Argyriou
    Department of Neurology, University Hospital of Patras, Patras, Greece
    Acta Neurol Scand 111:108-13. 2005
    ..To evaluate the epidemiological and clinical features of motor neuron disease (MND) in a region (835,000 inhabitants) of south-western Greece...
  2. doi Peripheral nerve damage associated with administration of taxanes in patients with cancer
    Andreas A Argyriou
    Department of Clinical Neurophysiology, National Hospital for Neurology and Neurosurgery, UCL, Institute for Neurology, Queen Square, London WC1N3BG, UK
    Crit Rev Oncol Hematol 66:218-28. 2008
    ..This review critically looks at the pathogenesis, incidence, risk factors, diagnosis, characteristics and management of taxanes-induced peripheral neuropathy. We also highlight areas of future research...
  3. ncbi The impact of paclitaxel or cisplatin-based chemotherapy on sympathetic skin response: a prospective study
    A A Argyriou
    Department of Neurology, University of Patras Medical School, Rion, Greece
    Eur J Neurol 12:858-61. 2005
    ..However, its role in the disclosure of small fibers neuropathy abnormalities is worth considering. Further studies are warranted to address this important issue...
  4. ncbi Paclitaxel plus carboplatin-induced peripheral neuropathy. A prospective clinical and electrophysiological study in patients suffering from solid malignancies
    Andreas A Argyriou
    Dept of Neurology, Laboratory of Clinical Neurophysiology, University of Patras Medical School, P O Box 1045, Rion, Patras, Greece
    J Neurol 252:1459-64. 2005
    ..The current study intended to determine the incidence, severity and reversibility of paclitaxel plus carboplatin (CP)-induced peripheral neuropathy (CPPN) and to describe its clinical and electrophysiological features...
  5. doi Religiosity and its relation to quality of life in primary caregivers of patients with multiple sclerosis: a case study in Greece
    Andreas A Argyriou
    Department of Neurology, Saint Andrew s State General Hospital of Patras, 26335, Patras, Greece
    J Neurol 258:1114-9. 2011
    ..Further prospective studies with a population with the same and/or diverse religious and cultural backgrounds are needed to better elucidate the complex association between religiosity and QOL in primary caregivers of MS patients...
  6. ncbi Intracerebral haemorrhage as a rare complication of HSV-1 meningoencephalitis: case report and review of the literature
    Andreas A Argyriou
    Department of Neurology, Division of Infectious Diseases of the University Hospital of Patras, Rion Patras, Greece
    Scand J Infect Dis 38:63-6. 2006
    ..Despite the impressive imaging findings, the final outcome of the patient's progress was favourable...
  7. pmc Molecularly targeted therapies for dysimmune neuropathies
    Andreas A Argyriou
    Department of Neurology, Saint Andrew s State General Hospital of Patras, Greece
    Mol Med 15:283-7. 2009
    ..This review looks critically at recent developments in molecularly targeted therapies for dysimmune neuropathies and also highlights areas of future research to pursue...
  8. doi Cocaine use and abuse triggering sporadic young-onset amyotrophic lateral sclerosis
    Andreas A Argyriou
    Department of Neurology, Saint Andrew s State General Hospital of Patras, Patras, Greece
    Neurodegener Dis 8:146-8. 2011
    ..Our case supports the view that cocaine use and abuse may trigger a process of motor neuron degeneration by mechanisms implicating alterations in the neurobiology of the excitatory neurotransmitter glutamate and its receptors...
  9. ncbi Clinical and electrophysiological features of peripheral neuropathy induced by administration of cisplatin plus paclitaxel-based chemotherapy
    A A Argyriou
    Department of Neurology Laboratory of Clinical Neurophysiology, University of Patras Medical School, Rion Patras, Greece
    Eur J Cancer Care (Engl) 16:231-7. 2007
    ....
  10. ncbi Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy
    A A Argyriou
    Neurology Department, EMG ENG Laboratory, University of Patras Medical School, 26504, Rion Patras, Greece
    Neurology 67:2253-5. 2006
    ..The incidence of OxIN was strikingly decreased in patients receiving oxcarbazepine (31.2% vs 75%). Oxcarbazepine may prevent OxIN symptoms. Further larger placebo-controlled trials are warranted to confirm our results...
  11. doi F-wave characteristics as surrogate markers of spasticity in patients with secondary progressive multiple sclerosis
    Andreas A Argyriou
    EMG Laboratory, Department of Neurology, Saint Andrew s State General Hospital of Patras, Patras, Greece
    J Clin Neurophysiol 27:120-5. 2010
    ..Significant amplitude F-wave abnormalities occurred in patients with secondary progressive MS and hand spasticity, emphasizing the contribution of upper motor neurons damage in the genesis of F waves...
  12. doi Neuromyelitis optica: a distinct demyelinating disease of the central nervous system
    A A Argyriou
    Department of Neurology, Saint Andrew General Hospital of Patras, Patras, Greece
    Acta Neurol Scand 118:209-17. 2008
    ..We review and discuss the pathogenesis, epidemiology, diagnosis as well as recent advances in the treatment of NMO. We also highlight areas of future research...
  13. doi Myasthenia gravis initially presenting with pseudo-internuclear ophthalmoplegia
    Andreas A Argyriou
    Department of Neurology, Saint Andrew s General Hospital of Patras, 26335, Patras, Greece
    Neurol Sci 30:387-8. 2009
    ..We herein describe the case of a male patient who developed PINO, as an initial manifestation of MG...
  14. ncbi Psychosocial effects and evaluation of the health-related quality of life in patients suffering from well-controlled epilepsy
    Andreas A Argyriou
    General Hospital of Kos Island, Dept of Internal Medicine, Kos, Greece
    J Neurol 251:310-3. 2004
    ..To record the impact of epilepsy on the psychological health and HRQOL of patients suffering from mild epilepsy in a rural area of southeastern Greece...
  15. doi Multiple sclerosis and reproductive risks in women
    Andreas A Argyriou
    Department of Neurology, Saint Andrew s General Hospital of Patras, Greece
    Reprod Sci 15:755-64. 2008
    ..Breastfeeding and epidural anaesthesia are not associated with increased incidence of post-partum relapses...
  16. doi Quality of life and emotional burden of primary caregivers: a case-control study of multiple sclerosis patients in Greece
    Andreas A Argyriou
    Department of Neurology, Saint Andrew s State General Hospital of Patras, 26335 Patras, Greece
    Qual Life Res 20:1663-8. 2011
    ..Our aim was to assess the perceived emotional burden and quality of life (QOL) in a sample of Greek primary caregivers of patients with multiple sclerosis (MS)...
  17. doi Co-occurrence of brain tumours and demyelination of the central nervous system: coincidence or interrelation?
    A A Argyriou
    Department of Neurology, University Hospital of Patras, Patras, Greece
    Eur J Cancer Care (Engl) 17:616-8. 2008
    ..Our case bolsters the argument that in at least some cases, the occurrence of a brain tumour could predispose to CNS non-specific demyelination...
  18. ncbi Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial
    A A Argyriou
    Neurology Department, University of Patras, Medical School, PO Box 1045, Rion, Patras, Greece
    Neurology 64:26-31. 2005
    ..The authors conducted a pilot, randomized, open label with blind assessment, controlled trial to determine whether vitamin E supplementation has a neuroprotective effect in chemotherapy-induced peripheral nerve damage...
  19. doi The significance of second lumbrical-interosseous latency comparison in the diagnosis of carpal tunnel syndrome
    A A Argyriou
    Department of Neurology, Saint Andrew General Hospital of Patras, Patras, Greece
    Acta Neurol Scand 120:198-203. 2009
    ..To assess the significance of the second lumbrical-interosseous latency (2LI-DML) comparison in the diagnosis of carpal tunnel syndrome (CTS)...
  20. ncbi Peripheral neuropathy induced by administration of cisplatin- and paclitaxel-based chemotherapy. Could it be predicted?
    Andreas A Argyriou
    Neurology Department, University of Patras Medical School, P O Box 1045, Rion, Patras, Greece
    Support Care Cancer 13:647-51. 2005
    ..The goal of this study was to investigate the potential role of clinical and electrophysiological signs of chemotherapy-induced neurotoxicity (CIPN) in predicting the final outcome of CIPN...
  21. ncbi Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer
    Andreas A Argyriou
    Department of Neurology EMG Laboratory, University of Patras Medical School, Rion Patras, Greece
    Acta Oncol 46:1131-7. 2007
    ..The current prospective study sought to trace the incidence and severity of oxaliplatin-induced peripheral neuropathy (OXLIPN) and to determine its clinical and electrophysiological pattern...
  22. doi Assessing the quality of sleep in Greek primary caregivers of patients with secondary progressive multiple sclerosis: a cross-sectional study
    Andreas A Argyriou
    Department of Neurology, Saint Andrew s State General Hospital of Patras, Patras, Greece
    J Pain Symptom Manage 42:541-7. 2011
    ..To our knowledge, however, no data are available about the quality of sleep of the primary caregivers of patients with MS...
  23. ncbi Is advanced age associated with increased incidence and severity of chemotherapy-induced peripheral neuropathy?
    Andreas A Argyriou
    Department of Neurology Laboratory of Clinical Neurophysiology, University of Patras Medical School, P O Box 1045, Rion, Patras, Greece
    Support Care Cancer 14:223-9. 2006
    ..The current setting tested the hypothesis that advanced age would be strongly associated with increased incidence and severity of chemotherapy-induced peripheral neuropathy (CIPN)...
  24. ncbi Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation
    Andreas A Argyriou
    EMG Laboratory, Department of Neurology, University of Patras Medical School, Rion Patras, Greece
    J Pain Symptom Manage 32:237-44. 2006
    ..This study shows that vitamin E effectively and safely protects patients with cancer from the occurrence of paclitaxel-induced peripheral nerve damage. A double-blind, placebo-controlled trial is needed to confirm these results...
  25. ncbi A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results
    Andreas A Argyriou
    EMG ENG Laboratory, Department of Neurology, University of Patras Medical School, Rion Patras, Greece
    Support Care Cancer 14:1134-40. 2006
    ..A randomized, open label with blind assessment, controlled trial was performed to assess efficacy and adverse-event profile of vitamin E, given as supplementation for prophylaxis against cisplatin-induced peripheral neuropathy (CIPN)...
  26. ncbi Sympathetic skin response in patients with peripheral arterial occlusive disease
    Andreas A Argyriou
    Laboratory of Clinical Neurophysiology, Department of Neurology, University of Patras Medical School, P O Box 1045, 26504 Rion Patras, Greece
    Clin Neurophysiol 117:414-9. 2006
    ..The current study aimed to assess the viability of sympathetic sudomotor fibers in patients suffering from mild peripheral arterial occlusive disease (PAD)...
  27. ncbi Ulnar F wave generation assessed within 3 days after the onset of stroke in patients with relatively preserved level of consciousness
    Elisabeth Chroni
    Department of Neurology, University of Patras Medical School, Greece
    Clin Neurol Neurosurg 109:27-31. 2007
    ....
  28. ncbi F wave study in amyotrophic lateral sclerosis: assessment of balance between upper and lower motor neuron involvement
    Andreas A Argyriou
    EMG Laboratory, Department of Neurology, The University of Patras Medical School, P O Box 1045, 26504 Rion Patras, Greece
    Clin Neurophysiol 117:1260-5. 2006
    ..Furthermore, an interpretation of these F wave abnormalities in the context of upper (UMN) and lower motor neuron (LMN) dysfunction was attempted...
  29. doi An in vitro study, evaluating the effect of sunitinib and/or lapatinib on two glioma cell lines
    Efstathia Giannopoulou
    Clinical Oncology Laboratory, Division of Oncology, Department of Medicine, University Hospital of Patras, Patras Medical School, Rion, 26504, Greece
    Invest New Drugs 28:554-60. 2010
    ..We sought to assess the effect of sunitinib and lapatinib applied either alone or in combination, on U87 and M059K glioma cells...
  30. doi A review on oxaliplatin-induced peripheral nerve damage
    Andreas A Argyriou
    Department of Neurology, EMG Laboratory, University of Patras Medical School, Rion Patras, Greece
    Cancer Treat Rev 34:368-77. 2008
    ..However, the clinical data are still controversial. We herein review and discuss the pathogenesis, incidence, risk factors, diagnosis, characteristics and management of OXLIPN. We also highlight areas of future research...
  31. ncbi Quetiapine successfully treating oculogyric crisis induced by antipsychotic drugs
    Philippos Gourzis
    Department of Psychiatry, University of Patras Medical School, Rion Patras, Greece
    J Clin Neurosci 14:396-8. 2007
    ..Both our patients did not improve after withdrawal of these antipsychotics, but rather after quetiapine was administered...
  32. doi Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer
    Andreas A Argyriou
    Department of Neurology, St Andrew s State General Hospital of Patras, Patras, Greece
    Cancer 119:438-44. 2013
    ..The authors also specifically tested whether patients who had more symptoms of acute OXLIPN eventually would develop a more severe chronic, cumulative form of OXLIPN...
  33. ncbi Level of consciousness as a conditioning factor of F wave generation in stroke patients
    Elisabeth Chroni
    Department of Neurology, University of Patras Medical School, P O Box 1045, 26504 Rion Patras, Greece
    Clin Neurophysiol 117:315-9. 2006
    ..The current study aimed to investigate whether the level of consciousness influenced the F wave generation, as an independent factor...
  34. pmc The effect of stimulation technique on sympathetic skin responses in healthy subjects
    Elisabeth Chroni
    Dept of Neurology, Laboratory of Clinical Neurophysiology, University of Patras Medical School, 26504, Rion Patras, Greece
    Clin Auton Res 16:396-400. 2006
    ..Electrically generated SSRs have a longer delay and the delay is prolonged at the contralateral side. These factors should be taken into account when interpreting SSR data...
  35. doi Persistent suppression of postexercise facilitation of motor evoked potentials during alternate phases of bipolar disorder
    Elisabeth Chroni
    Department of Neurology, University Hospital of Patras, Rion Patras, Greece
    J Clin Neurophysiol 25:115-8. 2008
    ..Reduced postexercise facilitation was independent of the bipolar disorder phases, suggesting an invariable underlying association of the psychiatric pathophysiological mechanisms to impaired cortical excitability...
  36. doi Chemotherapy-induced peripheral neurotoxicity (CIPN): an update
    Andreas A Argyriou
    Department of Neurology, Saint Andrew s General Hospital of Patras, Greece
    Crit Rev Oncol Hematol 82:51-77. 2012
    ....
  37. doi Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature
    Andreas A Argyriou
    Department of Neurology, Saint Andrew s General Hospital of Patras, Greece
    Blood 112:1593-9. 2008
    ..This review looks critically at the pathogenesis, incidence, risk factors, diagnosis, characteristics, and management of BIPN, and highlights areas for future research...
  38. doi Bilateral drop foot secondary to a primary tumor in the conus medullaris
    Alexandra Makridou
    Department of Neurology, Saint Andrew s General Hospital of Patras, Patras, Greece
    Muscle Nerve 37:778-80. 2008
    ..To our knowledge, we describe for the first time the case of a male patient who developed bilateral drop foot as an initial manifestation of a primary tumor in the conus medullaris of the spinal cord, probably an astrocytoma...
  39. ncbi Quetiapine in the treatment of focal tardive dystonia induced by other atypical antipsychotics: a report of 2 cases
    Philippos Gourzis
    Department of Psychiatry, Medical School of Patras University, Rion Patras, Greece
    Clin Neuropharmacol 28:195-6. 2005
    ....
  40. ncbi Ionizing radiation affects epidermal growth factor receptor signalling and metalloproteinase secretion in glioma cells
    Maria Martinou
    Department of Radiation Oncology, University of Patras Medical School, University Campus, 26504 Patras, Greece
    Cancer Genomics Proteomics 8:33-8. 2011
    ..The effect of different doses of X(-)rays on apoptosis, proliferation, epidermal growth factor receptor (EGFR) and matrix metalloproteinase (MMP-2) expression was investigated in a human glioblastoma cell line...
  41. ncbi Wilson's disease and benign epilepsy of childhood with centrotemporal (rolandic) spikes
    Panagiotis Polychronopoulos
    Department of Neurology, University Hospital of Patras, 26504, Rion Patras, Greece
    Epilepsy Behav 8:438-41. 2006
    ..To our knowledge, we herein describe for the first time a patient with Wilson's disease who subsequently manifested BECTS. Our case bolsters the argument that in at least some cases, BECTS is associated with organic brain disease...
  42. ncbi Induction of the rabbit syndrome following coadministration of paroxetine, perphenazine, and amitriptyline
    Philippos Gourzis
    Department of Psychiatry, University of Patras, Medical School, Rion, Patras, Greece
    Clin Neuropharmacol 27:299-300. 2004
    ....
  43. pmc Recent advances relating to the clinical application of naked monoclonal antibodies in solid tumors
    Andreas A Argyriou
    Department of Medicine Division of Clinical Oncology, University Hospital, University of Patras Medical School, Rion Patras, Greece
    Mol Med 15:183-91. 2009
    ..Immune-mediated effects may be further exploited with the use of bivalent molecules...
  44. ncbi The effects of anti-VEGFR and anti-EGFR agents on glioma cell migration through implication of growth factors with integrins
    Konstantinos Dimitropoulos
    Clinical Oncology Laboratory, Division of Oncology, Department of Medicine, University Hospital of Patras, Patras Medical School, Rion, Greece
    Anticancer Res 30:4987-92. 2010
    ..Furthermore, this study sought to evaluate the effect of lapatinib in the formation of EGFR-integrin β(1) complex, as well as the effect of sunitinib in the VEGFR-integrin β(3) and PDGFR-integrin β(3) complexes formation...
  45. doi Liability of the voltage-gated sodium channel gene SCN2A R19K polymorphism to oxaliplatin-induced peripheral neuropathy
    Andreas A Argyriou
    Division of Clinical Oncology, Department of Medicine, University Hospital of Patras, Rion Patras, Greece
    Oncology 77:254-6. 2009
    ..It was the aim of this study to test the hypothesis that the voltage-gated sodium channel gene SCN2A R19K polymorphism confers liability to oxaliplatin-induced peripheral neuropathy (OXLIPN)...
  46. ncbi A prospective study of familial versus sporadic Parkinson's disease
    Spiridon Papapetropoulos
    Department of Neurology, Regional University Hospital of Patras, Patras, Greece
    Neurodegener Dis 4:424-7. 2007
    ..Parkinson's disease (PD) is one of the most common neurodegenerative disorders. Most cases are sporadic but about 10-15% of patients have a positive family history of PD...
  47. pmc Molecularly targeted therapies for malignant gliomas
    Andreas A Argyriou
    Department of Medicine, Division of Clinical Oncology, University Hospital, University of Patras Medical School, Rion Patras, Greece
    Mol Med 15:115-22. 2009
    ....
  48. doi Frontotemporal and striatal SPECT abnormalities in myoclonus-dystonia: phenotypic and pathogenetic considerations
    Spiridon Papapetropoulos
    Department of Neurology, Regional University Hospital of Patras, Patras, Greece
    Neurodegener Dis 5:355-8. 2008
    ..A review of the literature on the phenotypic and pathogenetic considerations for MD is also presented...
  49. ncbi Lunar phases and seizure occurrence: just an ancient legend?
    P Polychronopoulos
    Department of Neurology, University of Patras Medical School, Rion Patras, Greece
    Neurology 66:1442-3. 2006
    ..A significant clustering of seizures around the full moon period was observed, supporting the ancient belief of periodic increased seizure frequency during full-moon days...
  50. ncbi Factors associated with poor compliance of patients with epilepsy driving restrictions
    P Polychronopoulos
    Department of Neurology, University of Patras Medical School, 26504, Rion Patras, Greece
    Neurology 67:869-71. 2006
    ..The results showed that patients with epilepsy do not comply with driving restrictions, mainly for employment-related reasons...
  51. ncbi Suicidal ideation in prisoners: risk factors and relevance to suicidal behaviour. A prospective case-control study
    Nicoletta P Lekka
    Department of Psychiatry, University of Patras Medical School, 26500, Rion, Patras, Greece
    Eur Arch Psychiatry Clin Neurosci 256:87-92. 2006
    ..To investigate risk factors for suicidal ideation (SI) in prisoners, as well as the prediction of suicidal behaviour by SI...
  52. doi Treatment options for malignant gliomas, emphasizing towards new molecularly targeted therapies
    Andreas A Argyriou
    Department of Medicine Division and Laboratory of Oncology, University Hospital, University of Patras Medical School, Rion Patras 26504, Greece
    Crit Rev Oncol Hematol 69:199-210. 2009
    ..We also highlight areas of future research...
  53. ncbi The significance of intact sympathetic skin responses in carpal tunnel syndrome
    A A Argyriou
    Laboratory of Clinical Neurophysiology, Department of Neurology, University of Patras Medical School, Rion Patras, Greece
    Eur J Neurol 13:455-9. 2006
    ..In the present setting, SSR appeared to be independent of somatic afferent function and the corresponding sensory action potentials...
  54. pmc Promises and hurdles of undergraduate medical development in Greece
    Amalia A Ifanti
    Department of Educational Sciences and Early Childhood Education, University of Patras, Rio, Patras, Greece
    Adv Med Educ Pract 2:201-8. 2011
    ..In this paper we sought to explore undergraduate medical students' views about their professional development during their studies that are considered to be related to medical professionalism...
  55. doi Epothilone-induced peripheral neuropathy: a review of current knowledge
    Andreas A Argyriou
    Department of Neurology, Saint Andrew s State General Hospital of Patras, Patras, Greece
    J Pain Symptom Manage 42:931-40. 2011
    ..Ixabepilone (BMS-247550) is the main representative of these compounds. Peripheral neuropathy is a significant toxicity of epothilones, eventually resulting in dose modification and changes in the treatment plan...
  56. ncbi A case of fatal progressive neuropathy. Delayed consequence of multiple bites of a non-venomous snake?
    Elisabeth Chroni
    Department of Neurology, University of Patras Medical School, Rion Patras, Greece
    Clin Neurol Neurosurg 108:45-7. 2005
    ..5 months. The possibility that this unique neurological syndrome of fatal progressive neuropathy could be caused by either tetanus or an immune reaction initiated by snakebites is discussed...
  57. doi Effect of epoetin alpha therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy
    G Iconomou
    Division of Oncology, Department of Medicine, University of Patras Medical School, Greece
    Eur J Cancer Care (Engl) 17:535-41. 2008
    ....
  58. ncbi Dynamic F wave study in patients suffering from peripheral arterial occlusive disease
    A A Argyriou
    EMG Laboratory, Department of Neurology, University of Patras Medical School, Rion Patras, Greece
    Acta Neurol Scand 115:84-9. 2007
    ..To prospectively detect significant transient F wave abnormalities obtained after exercise in patients with peripheral arterial disease (PAD) and to assess the potential diagnostic sensitivity of dynamic F wave study in such a context...
  59. ncbi Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents
    A A Argyriou
    Department of Neurology, Saint Andrew s General Hospital of Patras, and Department of Pathology, University of Patras Medical School, Rion Patras, Greece
    J BUON 15:435-46. 2010
    ..We also highlight areas of future research to pursue...
  60. ncbi A case of L-dopa-responsive parkinsonian syndrome after low-dose oral methotrexate intake
    Spiridon Papapetropoulos
    Department of Neurology, Regional University Hospital, Patras, Greece
    Clin Neuropharmacol 27:95-8. 2004
  61. doi Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas
    Andreas A Argyriou
    Department of Medicine, Division of Clinical Oncology, University Hospital, University of Patras Medical School, Rion Patras, Greece
    Oncology 77:1-11. 2009
    ..We also highlight areas of future research to pursue...
  62. ncbi The impact of weekly dosing of epoetin alfa on the haematological parameters and on the quality of life of anaemic cancer patients
    P Heras
    Division of Clinical Oncology, Department of Medicine, General Hospital of Kos Island, Greece
    Eur J Cancer Care (Engl) 14:108-12. 2005
    ..001). In conclusion, the treatment of cancer patients with Ea once-weekly is effective and safe, improving their haematological parameters and QOL...
  63. ncbi Comparison of motor fluctuations and L-dopa-induced dyskinesias in patients with familial and sporadic Parkinson's disease
    S Papapetropoulos
    Department of Neurology, Medical School of Patras, Patras, Greece
    Eur J Neurol 11:115-9. 2004
    ..FPD may be associated with a higher prevalence and earlier onset of motor complications during the initial stages of the disease. Genetic factors may contribute to the specific characteristics of motor complications in fPD...
  64. ncbi The effect of vascular disease on late onset Parkinson's disease
    S Papapetropoulos
    Department of Neurology, Medical School of Patras, Rion, Greece
    Eur J Neurol 11:231-5. 2004
    ..In clinical grounds, these findings can be proved significant since early and aggressive prevention of vascular disease and treatment of vascular risk may contribute in controlling symptom severity in PD...
  65. ncbi Emotional distress in cancer patients at the beginning of chemotherapy and its relation to quality of life
    G Iconomou
    Department of Medicine, Division of Oncology, University of Patras Medical School, Rion, Patras, Greece
    J BUON 13:217-22. 2008
    ..Another objective was to explore the associations between emotional distress and quality of life (QoL), an endpoint of great importance in current cancer care...
  66. ncbi The usefulness of nerve conduction studies in objectively assessing oxaliplatin-induced peripheral neuropathy
    Andreas A Argyriou
    Oncologist 12:1371-2; author reply 1372-3. 2007
  67. ncbi The effect of depression on motor function and disease severity of Parkinson's disease
    Spiridon Papapetropoulos
    Department of Neurology, Medical School of Patras, Greece Department of Neurology, University of Miami, School of Medicine, Room 4004, 1501 NW 9th Avenue, Miami, FL 33136, USA
    Clin Neurol Neurosurg 108:465-9. 2006
    ..Approximately 40% of patients with Parkinson's disease (PD) experience symptoms of depression. Our aim was to evaluate the effect of depression on disease severity, motor function and other phenotypic characteristics of PD...
  68. ncbi Factors associated with drug-induced visual hallucinations in Parkinson's disease
    Spiridon Papapetropoulos
    Dept of Neurology, University of Miami, School of Medicine, Room 4004, 1501 NW 9th Avenue, Miami, FL 33136, USA
    J Neurol 252:1223-8. 2005
    ..The aim of this study was to identify possible risk factors and determine clinical characteristics associated with the development of visual hallucinations in PD...
  69. ncbi Association of cigarette smoking and depressive symptoms in a forensic population
    Nicoletta P Lekka
    Academic Clinical Psychiatry, University of Sheffield School of Medicine, The Longley Centre, Sheffield, United Kingdom
    Depress Anxiety 24:325-30. 2007
    ..Psychiatric screening for younger male individuals in forensic settings and targeted cognitive-behavioral interventions to treat depressed smokers may ameliorate the smoking abstinence rate in prisons...
  70. doi Is the G2019S LRRK2 mutation common in all southern European populations?
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida 33136, USA
    J Clin Neurosci 15:1027-30. 2008
    ..Accurate estimations of the frequency and penetrance of different LRRK2 mutations are essential for correct and cost-efficient use of genetic testing and proper genetic counseling of patients with Parkinson's disease...
  71. ncbi No correlation between the clinical severity of autonomic symptoms (SCOPA-AUT) and electrophysiological test abnormalities in advanced Parkinson's disease
    Spiridon Papapetropoulos
    Mov Disord 21:430-1. 2006